ExLibris header image
SFX Logo
Title: CRISPR-Cas9 delivery to hard-to-transfect cells via membrane deformation
Source:

Science Advances [2375-2548] Han, X yr:2015


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Oude Blenke, E. "CRISPR-Cas9 gene editing: Delivery aspects and therapeutic potential." Journal of controlled release 244.Pt B (2016): 139-148. Link to SFX for this item
2. Gallego Perez, D. "Topical tissue nano-transfection mediates non-viral stroma reprogramming and rescue." Nature nanotechnology 12.10 (2017): 974-979. Link to SFX for this item
3. Ratan, Zubair A. "CRISPR-Cas9: a promising genetic engineering approach in cancer research." Therapeutic advances in medical oncology. 10: 1758834018755089-1758834018755089. Link to SFX for this item
4. Haussecker, D. "Current issues of RNAi therapeutics delivery and development." Journal of controlled release 195 (2014): 49-54. Link to SFX for this item
5. Davis, BR. "Glass needle-mediated microinjection of macromolecules and transgenes into primary human blood stem/progenitor cells." Blood 95.2 (2000): 437-444. Link to SFX for this item
6. Liu, C. "Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications." Journal of controlled release 266.1 (2017): 17-26. Link to SFX for this item
7. Yang, X. "Applications of CRISPR-Cas9 mediated genome engineering." Military Medical Research 2.1 (2015): 11-6. Link to Full Text for this item Link to SFX for this item
8. Zhang, J. "Optimization of genome editing through CRISPR-Cas9 engineering." Bioengineered 7.3 (2016): 166-174. Link to Full Text for this item Link to SFX for this item
9. Lindsay Mosher, N. "Cancer gene therapy: innovations in therapeutic delivery of CRISPR-Cas9." Drug discovery today. 21: 17-21. Link to SFX for this item
10. Nandakumar, J. "A lentivirus-free inducible CRISPR-Cas9 system for efficient targeting of human genes." Analytical biochemistry. 530.C: 40-49. Link to SFX for this item
11. Murphy, F. "Insuring nanotech requires effective risk communication." Nature nanotechnology 12.8 (2017): 717-719. Link to SFX for this item
12. Smith, T. "In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers." Nature nanotechnology. 12.8: 813-820. Link to SFX for this item
13. Gronych, J. "Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling." Nature communications 6.1 (2015): 7391-7391. Link to Full Text for this item Link to SFX for this item
14. Sekijima, Y. "Recent progress in the understanding and treatment of transthyretin amyloidosis." Journal of clinical pharmacy and therapeutics 39.3 (2014): 225-33. Link to Full Text for this item Link to SFX for this item
15. Pye, Geoffrey W. "Preventive medicine success: thymoma removal in an African spot-necked otter (Lutra maculicollis)." Journal of zoo and wildlife medicine 41.4 (2010): 732-4. Link to SFX for this item
16. Moura de Carvalho Vicentini, Fabiana Testa N. "Delivery Systems and Local Administration Routes for Therapeutic siRNA." Pharmaceutical research 30.4 (2013): 915-931. Link to Full Text for this item Link to SFX for this item
17. Yang, S. "Advancements in the Field of Intravaginal siRNA Delivery." Journal of controlled release 167.1 (2013): 29-39. Link to SFX for this item
18. Allaume, X. "Retargeting of Rat Parvovirus H-1PV to Cancer Cells through Genetic Engineering of the Viral Capsid." Journal of virology 86.7 (2012): 3452-3465. Link to Full Text for this item Link to SFX for this item
19. Pesonen, S. "Oncolytic adenoviruses for the treatment of human cancer: focus on translational and clinical data." Molecular pharmaceutics 8.1 (2010): 12-28. Link to Full Text for this item Link to SFX for this item
20. Dirks, Peter B. "Brain tumor stem cells: The cancer stem cell hypothesis writ large." Molecular Oncology 4.5 (2010): 420-430. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced